D.B. Root & Company, LLC Bristol Myers Squibb CO Transaction History

D.B. Root & Company, LLC

$296 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $18,921 - $21,009	297 Added 1.59%	18,934 $1.21 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $70,178 - $79,598	1,068 Added 6.08%	18,637 $1.29 Million
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $26,296 - $31,138	384 Added 2.23%	17,569 $0
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $71 - $42,492	-553 Reduced 3.12%	17,185 $1.22 Million
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $8,787 - $9,677	-121 Reduced 0.68%	17,738 $1.37 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $27,174 - $32,584	442 Added 2.54%	17,859 $1.3 Million
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $22,417 - $26,133	418 Added 2.46%	17,417 $1.09 Million
Q3 2021 Oct 22, 2021	BUY	$59.17 - $69.31 $13,254 - $15,525	224 Added 1.34%	16,999 $1.01 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $8,110 - $8,832	131 Added 0.79%	16,775 $1.12 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $5,874 - $6,607	-99 Reduced 0.59%	16,644 $1.05 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $63,687 - $72,169	-1,103 Reduced 6.18%	16,743 $1.04 Million
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $30,782 - $34,111	-536 Reduced 2.92%	17,846 $1.08 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $9,264 - $10,831	169 Added 0.93%	18,382 $1.08 Million
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $69,089 - $100,403	1,489 Added 8.9%	18,213 $1.02 Million
Q4 2019 Jan 14, 2020	SELL	$49.21 - $64.19 $22,784 - $29,719	-463 Reduced 2.69%	16,724 $1.07 Million
Q3 2019 Oct 29, 2019	SELL	$42.77 - $50.71 $10,820 - $12,829	-253 Reduced 1.45%	17,187 $871,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $46,404 - $51,313	-1,040 Reduced 5.63%	17,440 $790,000
Q1 2019 Apr 12, 2019	SELL	$45.12 - $53.8 $251,950 - $300,419	-5,584 Reduced 23.2%	18,480 $882,000
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $13,701 - $17,767	-281 Reduced 1.15%	24,064 $1.25 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $18,378 - $20,729	-333 Reduced 1.35%	24,345 $1.51 Million
Q2 2018 Jul 25, 2018	BUY	$50.53 - $62.98 $12,986 - $16,185	257 Added 1.05%	24,678 $1.37 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $414,646 - $477,341	6,920 Added 39.54%	24,421 $1.55 Million
Q4 2017 Feb 22, 2018	BUY	$59.94 - $65.35 $1.05 Million - $1.14 Million	17,501	17,501 $1.07 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.

Account